Maxacalcitol intravenous injection for dialysis 5μg “Nipro”, manufactured by Shionogi Pharma, contains Maxacalcitol. This injectable vitamin D3 analog is indicated for treating secondary hyperparathyroidism in patients receiving maintenance dialysis. It has a YJ code of 3112401A2057 and a standard of 5 μg 1 mL 1 tube.
Maxacalcitol intravenous injection for dialysis 5μg “Nipro”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →